35,130 results on '"Pheochromocytoma"'
Search Results
2. [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
3. 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
4. Diagnosis of Pheochromocytoma
5. Project: Every Child for Younger Patients With Cancer
6. Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
7. Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
8. Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
9. Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors (212-Pb]-VMT)
10. Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). (LUPARPED)
11. Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
12. Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma (SNIPP)
13. 18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
14. Iodine I 131 Metaiodobenzylguanidine in Treating Patients with Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
15. Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
16. Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
17. Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
18. Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
19. Phenoxybenzamine Versus Doxazosin in PCC Patients (PRESCRIPT)
20. Institutional Registry of Rare Diseases
21. Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
22. Metanephrines in Obstructive Sleep Apnoea
23. Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
24. 'Receptor Radionuclide Therapy With 177Lu-DOTATOC (LUFOR)
25. In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
26. 131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol
27. Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
28. A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (Spencer)
29. Using the EHR to Advance Genomic Medicine Across a Diverse Health System
30. A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
31. 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
32. Hereditary Pheochromocytoma Assessment of Tumour Immunologies (HEPHESTOS)
33. The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma
34. Side-specific Factors for Intraoperative Hemodynamic Instability in Pheochromocytoma
35. Management of Hereditary Syndromes Associated with Pheochromocytoma/Paraganglioma
36. Adrenal Incidentaloma
37. Imaging in Adrenocortical Carcinoma and Malignant Pheochromocytoma
38. Genetics and Molecular Biology of Pheochromocytoma and Paraganglioma
39. Epidemiology, Presentation, Staging, and Prognostic Factors in Malignant Pheochromocytoma
40. Medical Treatment of Malignant Pheochromocytoma
41. Role of Radiotherapy in Adrenocortical Carcinoma and Pheochromocytoma
42. Radionuclide Treatment in Malignant Pheochromocytoma
43. Preclinic and Translational Research in Adrenal Malignancies
44. Pathology of Adrenocortical Carcinoma and Malignant Pheochromocytoma
45. Surgery for Malignant Pheochromocytoma
46. The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)
47. Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
48. First-line Anlotinib Combined With Penpulimab for Advanced Pheochromocytoma: A Single-arm, Multicenter, Prospective Phase II Study
49. Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
50. Familial Investigations of Childhood Cancer Predisposition (SJFAMILY)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.